Key Takeaways
- Shares of Palantir declined approximately 4.8% to $127.88 on Wednesday, halting a seven-session rally that had delivered 25% gains.
- The sell-off followed a Financial Times article highlighting potential risks from Democratic lawmakers targeting the company’s federal contracts.
- Palantir secured approximately $2.2 billion in government contract revenue during the 12 months since Trump’s return to the White House, marking a 65% annual increase.
- Technical indicators remain bearish with PLTR trading beneath both its 100-day and 200-day moving averages, maintaining a Death Cross pattern since February.
- Wall Street maintains a Buy consensus rating with an average target price of $174.10; the company’s next earnings release is anticipated for August 3.
Shares of Palantir Technologies (PLTR) experienced a significant setback on Wednesday, breaking a streak of seven consecutive winning sessions. The stock declined roughly 4.8% to close at $127.88, positioning it among the S&P 500’s poorest performers for the trading day.
Palantir Technologies Inc., PLTR
The downturn followed a Financial Times publication that detailed internal company concerns while highlighting the prospect of Democratic legislators leveraging subpoena authority to examine Palantir’s government engagements should they reclaim House majority status.
DA Davidson’s Gil Luria, speaking with Barron’s, attributed the stock movement directly to the published report. However, Luria challenged the political risk thesis, emphasizing Palantir’s continuous collaboration with the Department of Defense spanning five separate administrations from both major political parties.
“Each successive administration has opted to utilize Palantir’s capabilities to a greater extent than the one before it,” Luria noted.
The timing is notable. PLTR had concluded Tuesday’s session precisely at its 50-day moving average near $134. Wednesday’s downward reversal indicates the stock encountered resistance at that technical threshold before retreating.
Palantir did not provide a response to requests for commentary.
Congressional Concerns and Federal Revenue Growth
While political scrutiny of Palantir isn’t unprecedented, the FT article brought it into sharper focus. The company has faced ongoing criticism regarding its engagements with U.S. immigration authorities, defense departments, and involvement in Israel’s Gaza operations.
The heightened attention carries particular significance given the financial stakes involved. During the 12-month period following Trump’s White House return, the company recorded nearly $2.2 billion in federal contract revenueârepresenting a substantial 65% increase versus the previous year. Meanwhile, commercial revenue more than doubled during the same timeframe.
Any material interruption to these government contracts would represent a significant financial impact beyond mere reputational concerns.
Notably, investor Michael Burry has taken a short position against PLTR, contending that Anthropic is encroaching on Palantir’s artificial intelligence domain. CEO Alex Karp has countered this perspective, maintaining that large-scale AI models generate challenges that Palantir’s solutions specifically address.
Technical Analysis of PLTR
The overall technical landscape remains challenging for the stock. PLTR currently trades 18.6% beneath its 200-day moving average of $157.31 and 7.9% below its 100-day moving average of $139.05. A Death Cross patternâoccurring when the 50-day moving average crosses below the 200-dayâemerged in February and persists.
Year-to-date in 2026, Palantir shares have declined 29% and currently sit 39% below the all-time closing peak of $207.18 established on November 3, 2025.
The recent upward momentum had provided temporary optimism. Following a June 25 bottom of $107.27, PLTR surged 25% across seven trading sessions. This rally gained support from an announced collaboration with Nvidia focused on developing specialized AI systems for federal agencies, accompanied by a DA Davidson upgrade to Buy with a $175 price objective.
Wednesday’s decline disrupted this positive momentum.
Investors now turn their attention to the company’s upcoming quarterly results, projected for August 3. Analyst estimates call for earnings per share of 33 cents, up from 16 cents in the year-ago quarter, with revenue forecast at $1.81 billion versus $1.00 billion in the comparable prior-year period.
The stock maintains a consensus Buy rating across analyst coverage, with an average price target of $174.10.





